IPCALAB.NS Profit & Loss
Ipca Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹62.44 Bn | ₹77.05 Bn | ₹89.40 Bn | ₹96.46 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹1.26 Bn | ₹1.25 Bn | ₹0.93 Bn | ₹1.74 Bn | OtherIncome |
| Total Income | ₹63.70 Bn | ₹78.30 Bn | ₹90.32 Bn | ₹98.21 Bn | Income |
| Cost of Materials Consumed | ₹17.09 Bn | ₹22.16 Bn | ₹22.77 Bn | ₹23.44 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹4.97 Bn | ₹4.90 Bn | ₹5.48 Bn | ₹5.33 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹1.01 Bn | ₹-1.31 Bn | ₹-0.46 Bn | ₹-0.54 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹12.88 Bn | ₹17.08 Bn | ₹19.84 Bn | ₹21.60 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.46 Bn | ₹1.38 Bn | ₹0.85 Bn | ₹0.76 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹2.62 Bn | ₹3.57 Bn | ₹3.98 Bn | ₹4.18 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹17.23 Bn | ₹21.00 Bn | ₹24.51 Bn | ₹26.85 Bn | OtherExpenses |
| Total Expenses | ₹56.25 Bn | ₹68.79 Bn | ₹76.96 Bn | ₹81.62 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹7.45 Bn | ₹9.50 Bn | ₹13.36 Bn | ₹16.59 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹-1.08 Bn | ₹-2.05 Bn | ₹-0.86 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹7.45 Bn | ₹8.43 Bn | ₹11.31 Bn | ₹15.73 Bn | ProfitBeforeTax |
| Tax Expense | ₹2.53 Bn | ₹3.13 Bn | ₹3.44 Bn | ₹3.81 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹4.79 Bn | ₹5.23 Bn | ₹7.85 Bn | ₹11.84 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹4.71 Bn | ₹5.47 Bn | ₹7.38 Bn | ₹11.41 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹18.58 | ₹21.57 | ₹29.08 | ₹44.98 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹18.58 | ₹21.57 | ₹29.08 | ₹44.98 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from IPCALAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).